共 278 条
[1]
Mili N(2021)Obesity, metabolic syndrome, and cancer: pathophysiological and therapeutic associations Endocrine 74 478-497
[2]
Paschou SA(2020)Obesity, type 2 diabetes, and Cancer risk Front Oncol 10 615375-e15
[3]
Goulis DG(2018)Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment Lancet Diabetes Endocrinol 6 e6-1241
[4]
Dimopoulos MA(2017)Metabolic cooperation and competition in the tumor microenvironment: implications for therapy Front Oncol 7 68-1570
[5]
Lambrinoudaki I(2015)Metabolic competition in the tumor microenvironment is a driver of Cancer progression Cell 162 1229-1101
[6]
Psaltopoulou T(2021)Treatment of lymphomas via regulating the signal transduction pathways by natural therapeutic approaches: a review Leuk Res 104 106554-3017
[7]
Scully T(2007)Obesity and risk of non-Hodgkin's lymphoma: a meta-analysis Int J Cancer 121 1564-2897
[8]
Ettela A(2010)Obesity and the risk for a hematological malignancy: leukemia, lymphoma, or myeloma Oncologist 15 1083-489
[9]
LeRoith D(2020)Increased lipid metabolism impairs NK cell function and mediates adaptation to the lymphoma environment Blood 136 3004-17
[10]
Gallagher EJ(2018)The relation of obesity-related hormonal and cytokine levels with multiple myeloma and non-Hodgkin lymphoma Front Oncol 8 103-2151